Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Grade Intraepithelial Neoplasia of Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00703196
What this trial is testing

Folic Acid Clinical Trial for the Prevention of Cervical Cancer

Who this might be right for
Cervical CancerPrecancerous Condition
University of Alabama at Birmingham 368
Not applicableLooking for participantsNCT07429071
What this trial is testing

Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.

Who this might be right for
Womens HealthCervical DysplasiaCervical Intraepithelial Neoplasia (CIN)+2 more
University of Aarhus 70
Testing effectiveness (Phase 2)Ended earlyNCT00708942
What this trial is testing

Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1

Who this might be right for
Cervical Intraepithelial Neoplasia
Photocure 83
Not applicableUnknownNCT06314113
What this trial is testing

Evaluation of Oral EGCG Treatment for L-SIL Associated With HPV Infection

Who this might be right for
Low-Grade Intraepithelial Neoplasia of Cervix
University of Palermo 50
Not applicableStudy completedNCT00632190
What this trial is testing

Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy

Who this might be right for
Cervical CancerPrecancerous Condition
British Columbia Cancer Agency 1,800
Not applicableUnknownNCT05595252
What this trial is testing

Retrospective Study on the Evolution of CIN 1 to 3 in Per and Postpartum in Nancy From 2014 to 2022

Who this might be right for
Cervical Intraepithelial Neoplasia
Central Hospital, Nancy, France 100
Testing effectiveness (Phase 2)Study completedNCT00513526
What this trial is testing

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Who this might be right for
InfectionPrecancerous Condition
AIDS Malignancy Consortium 112
Not applicableStudy completedNCT00458562
What this trial is testing

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

Who this might be right for
Cervical CancerPrecancerous Condition
University of Washington 1,680
Not applicableStudy completedNCT00653146
What this trial is testing

The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia

Who this might be right for
Cervical CancerPrecancerous Condition
Fox Chase Cancer Center 186
Not applicableLooking for participantsNCT05371353
What this trial is testing

Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine

Who this might be right for
HPV InfectionsCervical Cancer Stage IIaVaginal Cancer+4 more
Shanghai Bovax Biotechnology Co., Ltd. 600
Large-scale testing (Phase 3)Study completedNCT00156026
What this trial is testing

Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1

Who this might be right for
Cervical Intraepithelial Neoplasia
Ontario Clinical Oncology Group (OCOG) 415
Not applicableNot Yet RecruitingNCT07379905
What this trial is testing

MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1)

Who this might be right for
Low-grade Cervical Intraepithelial NeoplasiaModucare
Aristotle University Of Thessaloniki 182
Early research (Phase 1)Study completedNCT03676101
What this trial is testing

Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancersVulvar CancerVaginal Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 90
Early research (Phase 1)Study completedNCT04490512
What this trial is testing

Study of FluBHPVE6E7 in HPV-16 Infected Women

Who this might be right for
HPV Infection
BlueSky Immunotherapies GmbH 28
Early research (Phase 1)WithdrawnNCT02337842
What this trial is testing

Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)

Who this might be right for
Gastroenteritis Norovirus
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableUnknownNCT06491888
What this trial is testing

Randomized Controlled Study of Photoelectric Detection in Cervical Cancer Screening

Who this might be right for
Uterine Cervical CancerCervical Intraepithelial NeoplasiaHigh Grade Squamous Intraepithelial Lesions+1 more
Lei Li 4,200
Not applicableEnded earlyNCT02574442
What this trial is testing

Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer

Who this might be right for
Precancerous ConditionCervical Cancer
British Columbia Cancer Agency 60
Not applicableNot Yet RecruitingNCT07730645
What this trial is testing

Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2 (CIN2)Cervical Intraepithelial Neoplasia Grade 2CIN2
University Hospital Tuebingen 264
Not applicableStudy completedNCT04400578
What this trial is testing

TRICIN: Prospective Study on the Efficacy of Single Topical Trichloroacetic Acid (TCA) 85% in the Treatment of Cervical Intraepithelial Neoplasia (CIN 1/2)

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 1Cervical Intraepithelial Neoplasia Grade 2
Krankenhaus Barmherzige Schwestern Linz 102
Large-scale testing (Phase 3)UnknownNCT04895020
What this trial is testing

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Next Page